Provided by Tiger Trade Technology Pte. Ltd.

National Healthcare

135.31
-0.3500-0.26%
Post-market: 135.310.00000.00%16:12 EST
Volume:77.78K
Turnover:10.43M
Market Cap:2.10B
PE:20.87
High:135.34
Open:135.03
Low:132.49
Close:135.66
52wk High:144.53
52wk Low:89.14
Shares:15.52M
Float Shares:12.46M
Volume Ratio:1.02
T/O Rate:0.62%
Dividend:2.50
Dividend Rate:1.85%
EPS(TTM):6.48
EPS(LYR):6.62
ROE:10.12%
ROA:4.95%
PB:1.99
PE(LYR):20.44

Loading ...

National Healthcare Properties Appoints Scott Humphrey to Board of Directors

Reuters
·
Jan 13

New Hope Corporation Limited's (ASX:NHC) Earnings Are Not Doing Enough For Some Investors

Simply Wall St.
·
Jan 13

Press Release: National Healthcare Properties Announces Preferred Stock Dividends

Dow Jones
·
Dec 20, 2025

National HealthCare (NHC): Reassessing Valuation After Outperform Rating Reaffirmed Despite Recent Insider Share Sale

Simply Wall St.
·
Dec 20, 2025

National Healthcare Corporation Sr. VP Operations Timothy J. Shelly Reports Disposal of Common Shares

Reuters
·
Dec 19, 2025

NHC Foods Unit Intra Metal Trading Rebrands to NHC International

MT Newswires Live
·
Dec 16, 2025

National Healthcare Properties Secures $550 Million Senior Unsecured Credit Facility

Reuters
·
Dec 12, 2025

Livzon Pharmaceutical Group Secures Inclusion of Products in China’s National Reimbursement Drug List

Reuters
·
Dec 08, 2025

Xuanzhu Biopharmaceutical's Anjiuwei Included in 2025 NRDL

Reuters
·
Dec 08, 2025

Jiangsu Hengrui Medicine Drugs Added to China’s National Reimbursement Drug List

Reuters
·
Dec 07, 2025

CARsgen's Zevor-Cel Approved in China for Relapsed/Refractory Multiple Myeloma

Reuters
·
Dec 07, 2025

Akeso's Five Innovative Drugs Gain Full Inclusion in China's 2025 National Reimbursement Drug List

Reuters
·
Dec 07, 2025

Should Executive Changes and Insider Selling at National HealthCare (NHC) Prompt Investors to Reevaluate Their Outlook?

Simply Wall St.
·
Nov 30, 2025

How Technical Downtrend and New Production Forecasts at New Hope (ASX:NHC) Have Changed Its Investment Story

Simply Wall St.
·
Nov 29, 2025

A Fresh Look at New Hope (ASX:NHC) Valuation Following AGM Approvals and 2026 Production Update

Simply Wall St.
·
Nov 28, 2025

National Healthcare Corporation CEO Stephen Flatt Reports Disposal of Common Shares

Reuters
·
Nov 26, 2025

How Will New Board Appointment and Leadership Transition Shape National HealthCare’s Strategy for NHC Investors?

Simply Wall St.
·
Nov 23, 2025

National Healthcare Q3 Adjusted EPS USD 1.58

Reuters
·
Nov 20, 2025

National Healthcare Properties Names Andrew T. Babin Chief Financial Officer

Reuters
·
Nov 19, 2025

National Healthcare Corporation Files Initial Beneficial Ownership Statement; Director Lisa Piercey Listed as Reporting Person

Reuters
·
Nov 18, 2025